rs1060499540
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PM1PM2PM5PP3_StrongPP5_Moderate
The NM_002609.4(PDGFRB):c.2549A>T(p.Asp850Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D850G) has been classified as Uncertain significance.
Frequency
Consequence
NM_002609.4 missense
Scores
Clinical Significance
Conservation
Publications
- acroosteolysis-keloid-like lesions-premature aging syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
- myofibromatosis, infantile, 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndromeInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
- basal ganglia calcification, idiopathic, 4Inheritance: AD Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- bilateral striopallidodentate calcinosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- infantile myofibromatosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary progressive mucinous histiocytosisInheritance: AD Classification: LIMITED Submitted by: G2P
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PDGFRB | NM_002609.4 | c.2549A>T | p.Asp850Val | missense_variant | Exon 18 of 23 | ENST00000261799.9 | NP_002600.1 | |
| PDGFRB | NM_001355016.2 | c.2357A>T | p.Asp786Val | missense_variant | Exon 17 of 22 | NP_001341945.1 | ||
| PDGFRB | NM_001355017.2 | c.2066A>T | p.Asp689Val | missense_variant | Exon 18 of 23 | NP_001341946.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Infantile myofibromatosis Pathogenic:1
This somatic mutation was found in two patients with myofibromatosis. It strongly activates PDGFRB signaling in cell culture (gain of function). It is homologous to pathogenic mutations in receptors of the same family, such as PDGFRA D842V and KIT D816V (in gastrointestinal stromal tumors). We sequenced PDGFRB in myofibromatosis cases using the Ion Torrent technology. All variants were confirmed by an alternative method (allele specific PCR or Sanger sequencing). Mutants were functionally characterized in experiments based on cell transfection. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at